Measurement of Bone Mineral Content to Facilitate an Objective Evalution of Limp Function in the Dog

1994 ◽  
Vol 07 (03) ◽  
pp. 118-123 ◽  
Author(s):  
M. M. Petersen ◽  
A. Wenck ◽  
Henriette Strøm ◽  
E. Svalastoga

SummaryThe aim of this study was to evaluate the feasibility of using measurements of bone mineral content (BMC) and bone mineral density (BMD) by dual photon absorptiometry (DPA; Gadolinium-153), as an objective measure of limb functional status in the dog. The in vitro accuracy error expressed as the standard error of the estimate (SEE) for BMC and BMD measurements was 3.2% and 1.1% respectively, and the precision in vivo for measurements of BMC and BMD in the distal diaphysis of the tibia and fibula was 2.1% and 1.9% respectively. A significant difference in bone mineral between right and left leg was not found in normal dogs, and in these dogs the average percentage intra-individual difference, between bone mineral in the legs with the highest bone density and the legs with the lowest density, was 2.2% and 3.7% for BMC and BMD respectively. However the BMC and BMD in eight clinical cases of unilateral lameness were significantly decreased in the affected legs, when compared to the healthy contralateral legs, by 20.4% (P = 0.01) and 18.3% (P = 0.01)respectively. Measurements of BMC and BMD by DP A in weight-bearing extremities in the dog showed that bone mineral is highly sensitive to decreased loading of the extremity. This method might well be used not only as an objective measure of limb activity, but also for measurement of prospective changes in bone mineral, following treatment of musculoskeletal diseases and injuries.The feasibility of using bone mineral measurements by dual photon absorptiometry, as an objective measure of limb functional status in the dog, was evaluated. Precision and accuracy were calculated from in vitro and in vivo studies. In eight cases of unilateral lameness bone mineral was significantly decreased (20%) in the affected legs when compared to the healthy contralateral legs.

2009 ◽  
Vol 11 (2) ◽  
pp. 275-285 ◽  
Author(s):  
Christina D. Economos ◽  
Miriam E. Nelson ◽  
Maria A. Fiatarone ◽  
Gerard E. Dallal ◽  
Steven B. Heymsfield ◽  
...  

1986 ◽  
Vol 7 (10) ◽  
pp. 761-770 ◽  
Author(s):  
J. Ph. PRAET ◽  
M. H. JONCKHEER ◽  
R. REYCHLER ◽  
L. A. VERBRUGGEN

1994 ◽  
Vol 35 (1) ◽  
pp. 45-52
Author(s):  
R. Valkema ◽  
H. Prpic ◽  
J. A. K. Blokland ◽  
J. A. J. Camps ◽  
S. E. Papapoulos ◽  
...  

A gamma camera was equipped with a special collimator and arm assembly for bone mineral measurements with dual photon absorptiometry (DPA). The system was evaluated in vitro and in vivo and compared both with a rectilinear DPA and a dual energy X-ray (DEXA) system. All 3 systems showed a linear response in measurements of 4 vials, containing different amounts of hydroxyapatite. Phantom measurements with the gamma camera system showed a precision of 1.6% to 2.8%. Results obtained in 8 healthy volunteers with rectilinear and gamma camera systems were well correlated (R2 = 0.78). With the photon beam directed from posterior to anterior, the separation of vertebrae was easy with the gamma camera system. We conclude that bone mineral measurements can be made with a gamma camera for assessment of fracture risk and in the decision process whether a patient needs treatment or not. For follow-up, the precision of DPA with a gamma camera is inadequate.


2000 ◽  
Vol 165 (3) ◽  
pp. 569-577 ◽  
Author(s):  
J Svensson ◽  
S Lall ◽  
SL Dickson ◽  
BA Bengtsson ◽  
J Romer ◽  
...  

Growth hormone (GH) is of importance for normal bone remodelling. A recent clinical study demonstrated that MK-677, a member of a class of GH secretagogues (GHSs), increases serum concentrations of biochemical markers of bone formation and bone resorption. The aim of the present study was to investigate whether the GHSs, ipamorelin (IPA) and GH-releasing peptide-6 (GHRP-6), increase bone mineral content (BMC) in young adult female rats. Thirteen-week-old female Sprague-Dawley rats were given IPA (0.5 mg/kg per day; n=7), GHRP-6 (0.5 mg/kg per day; n=8), GH (3.5 mg/kg per day; n=7), or vehicle administered continuously s.c. via osmotic minipumps for 12 weeks. The animals were followed in vivo by dual X-ray absorptiometry (DXA) measurements every 4th week. After the animals were killed, femurs were analysed in vitro by mid-diaphyseal peripheral quantitative computed tomography (pQCT) scans. After this, excised femurs and vertebrae L6 were analysed by the use of Archimedes' principle and by determinations of ash weights. All treatments increased body weight and total tibial and vertebral BMC measured by DXA in vivo compared with vehicle-treated controls. However, total BMC corrected for the increase in body weight (total BMC:body weight ratio) was unaffected. Tibial area bone mineral density (BMD, BMC/area) was increased, but total and vertebral area BMDs were unchanged. The pQCT measurements in vitro revealed that the increase in the cortical BMC was due to an increased cross-sectional bone area, whereas the cortical volumetric BMD was unchanged. Femur and vertebra L6 volumes were increased but no effect was seen on the volumetric BMDs as measured by Archimedes' principle. Ash weight was increased by all treatments, but the mineral concentration was unchanged. We conclude that treatment of adult female rats with the GHSs ipamorelin and GHRP-6 increases BMC as measured by DXA in vivo. The results of in vitro measurements using pQCT and Archimedes' principle, in addition to ash weight determinations, show that the increases in cortical and total BMC were due to an increased growth of the bones with increased bone dimensions, whereas the volumetric BMD was unchanged.


Sign in / Sign up

Export Citation Format

Share Document